How big is AdaptHealth Corp.?

As of Jun 18, AdaptHealth Corp. has a market capitalization of 1,148.41 million, with net sales of 3,246.36 million and a net profit of 81.96 million over the latest four quarters. The balance sheet shows shareholder's funds of 1,571.14 million and total assets of 4,577.72 million.

As of Jun 18, AdaptHealth Corp. has a market capitalization of 1,148.41 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 3,246.36 million and a net profit of 81.96 million for the latest four quarters.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 1,571.14 million and total assets of 4,577.72 million.

What does AdaptHealth Corp. do?

AdaptHealth Corp. is a U.S. provider of home healthcare equipment and medical supplies, with recent net sales of $778 million and a market cap of $1.15 billion. The company reported a net profit of -$6 million for March 2025.

Overview: <BR>AdaptHealth Corp. is a provider of home healthcare equipment and medical supplies in the United States, operating within the Finance industry and classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 778 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -6 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 1,148.41 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 13.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: 5.76% <BR>Price to Book: 0.73<BR><BR>Contact Details: <BR>Address: 220 W Germantown Pike Ste 250, PLYMOUTH MEETING PA: 19462 <BR>Tel: 1 610 6306357 <BR>Fax: 1 302 6365454

Should I buy, sell or hold AdaptHealth Corp.?

Who are in the management team of AdaptHealth Corp.?

As of March 2022, the management team of AdaptHealth Corp. includes Mr. Richard Barasch (Independent Chairman), Mr. Joshua Parnes (President and Director), and Mr. Luke McGee (CEO and Director), along with several independent directors on the Board.

As of March 2022, the management team of AdaptHealth Corp. includes the following individuals:<BR><BR>- Mr. Richard Barasch, Independent Chairman of the Board<BR>- Mr. Joshua Parnes, President and Director<BR>- Mr. Luke McGee, Chief Executive Officer and Director<BR><BR>Additionally, the Board of Directors features several independent directors: Mr. Terence Connors, Mr. Alan Quasha, Dr. Susan Weaver, Mr. David Williams, and Mr. Dale Wolf.

Is AdaptHealth Corp. overvalued or undervalued?

As of October 17, 2025, AdaptHealth Corp. is considered overvalued with a P/E ratio of 13 and a year-to-date return of -3.99%, significantly underperforming the S&P 500's 13.30% return and showing a 56.78% decline over the past three years.

As of 17 October 2025, AdaptHealth Corp. has moved from an attractive to an expensive valuation grade. The company appears to be overvalued based on its current metrics, with a P/E ratio of 13, a Price to Book Value of 0.77, and an EV to EBITDA ratio of 4.78. In comparison to peers, Nelnet, Inc. has a more favorable P/E ratio of 11.39, while H&E Equipment Services, Inc. is significantly higher at 34.29, indicating that AdaptHealth's valuation is not justified when looking at industry standards.<BR><BR>The company's recent stock performance shows a stark contrast to the S&P 500, with a year-to-date return of -3.99% compared to the S&P 500's 13.30%. Over the past three years, AdaptHealth's stock has declined by 56.78%, while the S&P 500 has increased by 81.19%, reinforcing the notion that the stock is currently overvalued.

Is AdaptHealth Corp. technically bullish or bearish?

As of October 31, 2025, AdaptHealth Corp. shows a bearish technical trend with weak indicators, despite outperforming the S&P 500 in the short term, while significantly underperforming over the past three years.

As of 31 October 2025, the technical trend for AdaptHealth Corp. has changed from mildly bearish to bearish. The weekly MACD is bearish, and the daily moving averages also indicate a bearish stance. Additionally, the weekly KST is bearish, while Bollinger Bands are showing a mildly bearish trend on both weekly and monthly time frames. The RSI shows no signal on both weekly and monthly periods, and Dow Theory indicates no trend in either time frame.<BR><BR>In terms of performance, AdaptHealth has outperformed the S&P 500 over the past week and month, with returns of 13.39% and 17.38% respectively, but it has significantly underperformed over longer periods, with a 3-year return of -50.00% compared to the S&P 500's 76.66%. Overall, the current technical stance is bearish, reflecting weakness in multiple indicators.